SpyGlass Pharma, Inc. Common Stock (SGP) vs SL Science Holding Ltd (SLBT)
A side-by-side comparison of SpyGlass Pharma, Inc. Common Stock and SL Science Holding Ltd across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
SGP
SpyGlass Pharma, Inc. Common Stock
$24.95HealthcareDelayed quote: Oct 6, 2026, 1:49 PM EDT
SLBT
SL Science Holding Ltd
$1.53HealthcareDelayed quote: Oct 6, 2026, 1:49 PM EDT
Total return — SGP vs SLBT
growth of $100 · dividends reinvested · last 1ySGP +15.1% (+15.1%/yr)SLBT -79.6% (-79.6%/yr)SGP compounded faster over this window
Log scale — wide-divergence pair
SGP SLBT
SGP vs SLBT: by the numbers
- •SLBT is the larger company ($855M vs $834M market cap).
- •Both run net losses; SGP's is the smaller (0.00% vs -173.85% net margin).
Metrics side by side
Valuation
| Metric | SGP | SLBT |
|---|---|---|
| P/B ratio | 3.59 | 374.43 |
Profitability
| Metric | SGP | SLBT |
|---|---|---|
| Gross margin | 0.00% | 35.27% |
| Operating margin | 0.00% | -174.65% |
| Net margin | 0.00% | -173.85% |
| ROE | -24.12% | -167.25% |
| ROIC | -26.54% | -163.39% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.